Table 1.
Demographic characteristics of the study population
| 2000 N (%) 218 |
2002 N (%) 186 |
2008 N (%) 269 |
2010 N (%) 288 |
2012 N (%) 274 |
p value | |
|---|---|---|---|---|---|---|
| EIR | 482.6 | 409.9 | 12.3 | 2.2 | 0.3 | |
| Treatment | Chloroquine | Chloroquine | ACT | ACT | ACT | |
| Sex | ||||||
| Male | 117 (53.67) | 90 (48.39) | 128 (47.58) | 136 (47.22) | 125 (45.62) | 0.09 |
| Female | 101 (46.33) | 96 (51.61) | 141 (52.42) | 152 (52.78) | 149 (54.38) | |
| Age | ||||||
| Mean | 27.48 | 29.51 | 26.72 | 25.3 | 26.77 | <0.001 |
| [min–max] | [5–89] | [3.4–80.0] | [4.8–78] | [3.4–75.1] | [5.2–90.9] | |
| 95% CI | [24.9; 30.0] | [26.7; 32.3] | [24.5; 28.9] | [23.2; 27.4] | [24.6; 29.0] | |
| Age groups (years) | ||||||
| <7 | 16 (7.34) | 15 (8.06) | 20 (7.44) | 24 (8.33) | 14 (5.11) | <0.001 |
| (7–15) | 65 (29.82) | 35 (18.82) | 75 (27.88) | 93 (32.29) | 91 (33.21) | |
| >15 | 137 (62.84) | 136 (73.12) | 174 (64.68) | 171 (59.38) | 169 (61.68) | |